Osaic Holdings’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-450
Closed -$31.2K 7862
2025
Q3
$31.2K Hold
450
﹤0.01% 5633
2025
Q2
$26.2K Buy
+450
New +$25.4K ﹤0.01% 5507
2024
Q3
Sell
-1,444
Closed -$84.9K 7404
2024
Q2
$84.9K Sell
1,444
-599
-29% -$33.4K ﹤0.01% 4264
2024
Q1
$116K Buy
2,043
+160
+8% +$9.33K ﹤0.01% 4140
2023
Q4
$109K Hold
1,883
﹤0.01% 4377
2023
Q3
$94.2K Buy
1,883
+644
+52% +$33.9K ﹤0.01% 4557
2023
Q2
$65.2K Hold
1,239
﹤0.01% 4762
2023
Q1
$61K Hold
1,239
﹤0.01% 4818
2022
Q4
$61K Buy
1,239
+38
+3% +$1.82K ﹤0.01% 4789
2022
Q3
$54K Hold
1,201
﹤0.01% 4836
2022
Q2
$49K Hold
1,201
﹤0.01% 4974
2022
Q1
$52K Hold
1,201
﹤0.01% 5060
2021
Q4
$59K Hold
1,201
﹤0.01% 5018
2021
Q3
$61K Hold
1,201
﹤0.01% 4948
2021
Q2
$64K Hold
1,201
﹤0.01% 4846
2021
Q1
$63K Sell
1,201
-410
-25% -$22.9K ﹤0.01% 4704
2020
Q4
$86K Hold
1,611
﹤0.01% 4160
2020
Q3
$77K Hold
1,611
﹤0.01% 4009
2020
Q2
$76K Hold
1,611
﹤0.01% 3885
2020
Q1
$60K Buy
+1,611
New +$66.6K ﹤0.01% 3835

Other funds holding BBP

Osaic Holdings's BBP Position: Q4 2025 in Review

Osaic Holdings sold out of Virtus Biotech ETF (BBP) in Q4 2025, closing a stake of 450 shares — an estimated $31.2K sold.

Osaic Holdings first reported a position in BBP in Q1 2020 and held it in 20 quarters. The position peaked at $116K in Q1 2024. 20 funds tracked by Wall St. Rank hold BBP as of Q4 2025.

  • Osaic Holdings reported no remaining Virtus Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 450 Virtus Biotech ETF shares in Q4 2025, an estimated $31.2K.
  • Osaic Holdings first reported a position in Virtus Biotech ETF in Q1 2020 and held it in 20 quarters.
  • Osaic Holdings's Virtus Biotech ETF position peaked at $116K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.